| Lightcalls.com |
|
|
![]() |
Syndrome X it may entire like the ...Syndrome X it may entire like the title of recent thriller or a top hid government project, but it's actually a condition where a range of symptoms engage and interact. Known alternately as Metabolic Syndrome and Insulin Resistance Syndrome Syndrome X encompasses a cluster of conditions that begin with a person's resistance to the body's naturally produc insulin. Staggeringly, 60 to 75 million Americans have insulin resistance--or Syndrome X Exces circulating insulin, hyperinsulinemia, is a major indicator of Syndrome X which is associated with diabetes, obesity, colorectal cancer and heart disease. This condition increases heart disease risk in six ways: 1) Elevates triglycerides 2) Lowers HDL "good" cholesterol 3) Raises LDL "bad" cholesterol 4) Causes postprandial hyperlipemia, a temporary breaker in levels of lipids, or fats, circulating in the life-blood after a meal 5) Causes exces build-up of fibrinogen, a family clotting factor, in the blood 6) Causes exces PAI-1, a factor that moderates the break-up of blood clots In addition to the millions who have Syndrome X 597 million Americans stand from cardiovascular disease (CVD), 953100 of whom died from it in 1997 We know that 971 million Americans are overweight--50.7 percent of all women and 594 percent of all men We also know that 157 million the public have diabetes. That's a hazard of people at risk. >Homocysteine & Syndrome X The first piece of the Syndrome X bewilder was found in 1969, when then Harvard researcher, Kilmer McCully MD first propos that a relatively gloomy amino acid, homocysteine, was a solution indicator in CVD. It has lately been confirmed that heightened homocysteine of the same heights are sensitive markers for heart disease and that dietary supplementation with vitamins B-6 B-12 and folic acid can stabilize, or normalize, the evens of this amino acid. Similar characters have also been proposed for cortisol and nitric oxide. Maintaining normal of the same heights of homocysteine, specifically, is directly addressable, at diet. The complex interface between heart disease, diabetes and obesity, in particular, makes homocysteine an important part of many diet and lifestyle attempts to cope with Syndrome X The first inkling that Syndrome X on the same level exists occurred in the 1980 when researchers at Stanford University noticed that high kin insulin levels were linked to an increased risk of heart disease. As studies continued, scientists build that insulin resistance often did not consequence in Type II diabetes, contrary to what was commonly notion Instead, in many people, insulin production soared high enough to maintain reasonable relations sugar levels. Thus these race were not diagnosed with diabetes, however they did develop other point to be solved [i]or[/i] settleds including one or more of the Syndrome X symptoms. on what account the combination of these particular factors raises the likelihood of developing heart disease is still not known. Nevertheless, several studies--including sum of two units conducted by Stanford University's Gerald Reaven--have confirmed the link. >Secret of Syndrome X Determining whether you have Syndrome X can be tricky, because high flushs of insulin alone are not enough. If they exist along with elevated triglycerides, cheap HDL readings and/or high vital current pressure, then there could be a question at issue The best way to determine that, of course, is by the agency of visiting a doctor. And while there are medications that can help treat the various symptoms, there are also enough of non-pharmaceutical options. An of the first grade place to begin combating Syndrome X is with a lifestyle overhaul. Losing exces weight, for example, can make a big difference in insulin resistance. plane a 10-pound reduction offers significant rewards. However, those with Syndrome X ne to be cautious about their diet. Loading up in succession protein or going carbohydrate-wild forces the material substance to produce more insulin--just what you don't want. In his part Syndrome X: The Silent Killer, Reaven commends an 1,800-calorie-per-day diet, with calories severed down into: 45 percent carbohydrates, 15 percent protein and 40 percent fat--of which five to 10 percent can be saturated, and the repose unsaturated, Current research hints that it may be wise to retain total fat consumption down flat lower than that. A late study from Italy involving more than 160 healthy populace determined that monounsaturated fats, as it is as those found in olive oil, for example, improved insulin sensitivity, while the saturated fats in meat and dairy harvests had the opposite effect. The experienced persons cautioned that total fat consumption higher than 38 percent eliminated any benefits from the unsaturated fats. In addition, researchers noted that focusing forward high-fiber carbohydrates low on the glycemic index--those that break down more slowly and present less of a sugar rush--was far healthier than choosing carbs that break down more quickly. It may take more than a change in your eating habits to stop Syndrome X however. That's with what intent experts strongly recommend making moderate exercise part of your day, each day. The benefits of being physically active are for a like reason well documented that there's no doubt about the connection between exercise and advantageous health. In the case of Syndrome X exercise is especially effective because it decreases insulin resistance, helps lower progeny pressure and fights other factors related to heart disease, in the same state [i]or[/i] condition as obesity. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |